B

Biohit Oyj
OMXH:BIOBV

Watchlist Manager
Biohit Oyj
OMXH:BIOBV
Watchlist
Price: 2.3 EUR Market Closed
Market Cap: 34.8m EUR
Have any thoughts about
Biohit Oyj?
Write Note

Wall Street
Price Targets

BIOBV Price Targets Summary
Biohit Oyj

Wall Street analysts forecast BIOBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOBV is 2.75 EUR with a low forecast of 2.73 EUR and a high forecast of 2.84 EUR.

Lowest
Price Target
2.73 EUR
19% Upside
Average
Price Target
2.75 EUR
20% Upside
Highest
Price Target
2.84 EUR
23% Upside
Biohit Oyj Competitors:
Price Targets
ELMD
Electromed Inc
13% Upside
688626
Xiangyu Medical Co Ltd
116% Upside
301367
BMC Medical Co Ltd
11% Upside
RMD
Resmed Inc
4% Upside
TFX
Teleflex Inc
31% Upside
INMD
Inmode Ltd
14% Upside
MDT
Medtronic PLC
13% Upside
002901
Double Medical Technology Inc
53% Upside

Revenue
Forecast

Revenue Estimate
Biohit Oyj

For the last 8 years the compound annual growth rate for Biohit Oyj's revenue is 10%. The projected CAGR for the next 3 years is 16%.

10%
Past Growth
16%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Biohit Oyj

The compound annual growth rate of Biohit Oyj's operating income for the next 3 years is 19%.

N/A
Past Growth
19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Biohit Oyj

The compound annual growth rate of Biohit Oyj's net income for the next 3 years is 10%.

N/A
Past Growth
10%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOBV's stock price target?
Price Target
2.75 EUR

According to Wall Street analysts, the average 1-year price target for BIOBV is 2.75 EUR with a low forecast of 2.73 EUR and a high forecast of 2.84 EUR.

What is Biohit Oyj's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Biohit Oyj's revenue is 10%. The projected CAGR for the next 3 years is 16%.

What is Biohit Oyj's Operating Income forecast?
Projected CAGR
19%

The compound annual growth rate of Biohit Oyj's operating income for the next 3 years is 19%.

What is Biohit Oyj's Net Income forecast?
Projected CAGR
10%

The compound annual growth rate of Biohit Oyj's net income for the next 3 years is 10%.

Back to Top